, A Multicenter, 6-month, Open-Label Study of Xanax XR
in the treatment of
Adolescents with Panic Disorder or
Anxiety with Panic Attacks, total costs for the entire project- $90,410(Principal Investigator)
* 4/05/04-5/31/05 Pfizer Inc, A Multicenter, 18-week, Randomized, Double-Blind,Continuation Study of Xanax XR and Placebo in Adolescents with a Primary diagnosis of Panic Disorder, total costs for the entire project- $60,000, (Principal Investigator)
I found this data on a psychiatris